Kelly Financial Services LLC Gsk PLC Transaction History

Kelly Financial Services LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Jul 17, 2024	SELL	$16.13 - $44.61 $6,806 - $18,825	-422 Closed	0 $0
Q2 2022 Jul 17, 2024	BUY	$42.05 - $47.77 $12,657 - $14,378	301 Added 248.76%	422 $18.4 Million
Q1 2022 Jul 17, 2024	BUY	$40.23 - $47.74 $40 - $47	1 Added 0.83%	121 $5.27 Million
Q4 2021 Jul 17, 2024	BUY	$38.88 - $45.31 $1,827 - $2,129	47 Added 64.38%	120 $5.29 Million
Q3 2021 Jul 17, 2024	SELL	$38.79 - $43.16 $108,612 - $120,847	-2,800 Reduced 97.46%	73 $2.79 Million
Q2 2021 Jul 17, 2024	BUY	$36.52 - $41.46 $102,329 - $116,170	2,802 Added 3946.48%	2,873 $72,000
Q1 2021 Jul 17, 2024	BUY	$34.27 - $40.01 $34 - $40	1 Added 1.43%	71 $2.53 Million
Q4 2020 Jul 17, 2024	SELL	$34.07 - $39.94 $442 - $519	-13 Reduced 15.66%	70 $2.58 Million
Q3 2019 Jul 17, 2024	BUY	$40.46 - $43.52 $3,358 - $3,612	83 New	83 $3.54 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.